Financhill
Back

Cassava Sciences Quote, Financials, Valuation and Earnings

Buy
54

SAVA
Cassava Sciences

Last Price:
23.14
Seasonality Move:
-1.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Cassava Sciences Price Quote

$23.14
+0.02 (+7.33%)
(Updated: May 18, 2024 at 5:52 AM ET)

Cassava Sciences Key Stats

Buy
54
Cassava Sciences (SAVA) is a Buy

Day range:
$21.36 - $23.39
52-week range:
$12.32 - $32.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
23.91
P/B ratio:
14.11%

Volume:
772.8K
Avg. volume:
1.1M
1-year change:
-8.58%
Market cap:
$1.1B
Revenue:
$0
EPS:
$-2.17

How Much Does Cassava Sciences Make?

Data Unavailable

Is Cassava Sciences Growing As A Company?

Data Unavailable

Cassava Sciences Stock Price Performance

  • Did Cassava Sciences Stock Go Up Last Month?
    Cassava Sciences share price went up by 8.7% last month
  • Did SAVA's Share Price Rise Over The Last Year?
    SAVA share price fell by -8.58% over the past 1 year

What Is Cassava Sciences 52-Week High & Low?

Cassava Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cassava Sciences?

  • How Much Debt Does Cassava Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cassava Sciences Have?
    Cash and short term investments quarterly total is $124.2M
  • What Is Cassava Sciences’s Book Value Per Share?
    Book value per share is 1.82

Is Cassava Sciences Cash Flow Positive?

  • What Is SAVA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$87.9M
  • What Is Cassava Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $24.7M
  • What Is Cassava Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$57K

Cassava Sciences Return On Invested Capital

Data Unavailable

Cassava Sciences Earnings Date & Stock Price

Cassava Sciences Competitors

  • Who Are Cassava Sciences's Competitors?
    Below is a list of companies who compete with Cassava Sciences or are related in some way:
    • ACADIA Pharmaceuticals Inc (ACAD)
    • Amylyx Pharmaceuticals Inc (AMLX)
    • Cormedix Inc (CRMD)
    • Oragenics Inc (OGEN)
    • Vertex Pharmaceuticals Inc (VRTX)

Cassava Sciences Dividend Yield

Data Unavailable

Cassava Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.52%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 103.00
Upside from Last Price: 345.5%

Major Shareholders

  • How many SAVA shares are owned by institutional investors?
    21.2M SAVA shares are owned by institutional investors
  • How many SAVA shares are owned by insiders?
    2M SAVA shares are owned by insiders